1. Home
  2. ACNB vs QTTB Comparison

ACNB vs QTTB Comparison

Compare ACNB & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACNB
  • QTTB
  • Stock Information
  • Founded
  • ACNB 1857
  • QTTB 2015
  • Country
  • ACNB United States
  • QTTB United States
  • Employees
  • ACNB N/A
  • QTTB N/A
  • Industry
  • ACNB Major Banks
  • QTTB Biotechnology: Pharmaceutical Preparations
  • Sector
  • ACNB Finance
  • QTTB Health Care
  • Exchange
  • ACNB Nasdaq
  • QTTB Nasdaq
  • Market Cap
  • ACNB 413.5M
  • QTTB 434.0M
  • IPO Year
  • ACNB N/A
  • QTTB N/A
  • Fundamental
  • Price
  • ACNB $41.48
  • QTTB $3.59
  • Analyst Decision
  • ACNB Buy
  • QTTB Buy
  • Analyst Count
  • ACNB 3
  • QTTB 8
  • Target Price
  • ACNB $45.00
  • QTTB $29.14
  • AVG Volume (30 Days)
  • ACNB 16.3K
  • QTTB 669.8K
  • Earning Date
  • ACNB 01-23-2025
  • QTTB 11-07-2024
  • Dividend Yield
  • ACNB 3.09%
  • QTTB N/A
  • EPS Growth
  • ACNB N/A
  • QTTB N/A
  • EPS
  • ACNB 3.44
  • QTTB N/A
  • Revenue
  • ACNB $106,401,000.00
  • QTTB N/A
  • Revenue This Year
  • ACNB N/A
  • QTTB N/A
  • Revenue Next Year
  • ACNB $20.49
  • QTTB N/A
  • P/E Ratio
  • ACNB $12.06
  • QTTB N/A
  • Revenue Growth
  • ACNB N/A
  • QTTB N/A
  • 52 Week Low
  • ACNB $30.24
  • QTTB $3.02
  • 52 Week High
  • ACNB $50.72
  • QTTB $53.79
  • Technical
  • Relative Strength Index (RSI)
  • ACNB 32.61
  • QTTB 16.82
  • Support Level
  • ACNB $44.51
  • QTTB $3.02
  • Resistance Level
  • ACNB $46.90
  • QTTB $28.06
  • Average True Range (ATR)
  • ACNB 1.59
  • QTTB 2.02
  • MACD
  • ACNB -0.65
  • QTTB -0.96
  • Stochastic Oscillator
  • ACNB 16.06
  • QTTB 2.28

About ACNB ACNB Corporation

ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Bank which generates the majority of the revenue provides banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

Share on Social Networks: